We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Substance Use and Fitness

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01305902
First Posted: March 1, 2011
Last Update Posted: June 18, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
UConn Health
  Purpose
The purpose of this pilot study is to estimate the effect size of a contingency management procedure that reinforces walking at rates consistent with the American College of Sports Medicine recommendations of 10,000 or more steps per day in older adults. We expect that participants randomized to the contingency management intervention will increase walking to a greater degree than those assigned to a standard care condition.

Condition Intervention Phase
Substance Abuse Exercise Behavioral: contingency management Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Substance Use and Fitness: A Pilot Study of Contingency Management in Older Adults

Further study details as provided by UConn Health:

Primary Outcome Measures:
  • number of days on which participants walked the recommended number of steps [ Time Frame: Weeks 1-12 ]

Enrollment: 45
Study Start Date: January 2011
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: walking recommendations
Participants assigned to this condition will be instructed to wear a pedometer daily and scheduled for weekly meetings over for the next 12 weeks. Each week, they will be congratulated if they walked the target goal on any days, and encouraged to meet the goals for the upcoming week. However, they will not receive any tangible reinforcement for walking. The meetings will be brief (about 15 minutes) and will include discussions and handouts related to the health benefits of walking.
Experimental: contingency management for walking
Participants assigned to this condition will be asked to wear a pedometer daily and scheduled for weekly meetings over for the next 12 weeks. The meeting duration and structure will be similar to that in the standard treatment condition including the handouts, with one exception. Participants in this condition will earn tangible reinforcement in the form of prizes for walking the target number of steps per day.
Behavioral: contingency management
Participants assigned to the experimental group will earn chances to win prizes if they have walked the recommended number of steps.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 55 - 75 years
  • currently not physically active
  • willing and physically able as determined by physician approval to walk 10,000 steps per day
  • blood pressure of 120-159 mmHg systolic or 80-99 mmHg diastolic
  • willing to meet with research staff weekly for 12 weeks

Exclusion Criteria:

  • psychiatric or physical illness that could interfere with participation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01305902


Locations
United States, Connecticut
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030
Sponsors and Collaborators
UConn Health
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Nancy M Petry, Ph.D. University of Conncecticut Health Center
  More Information

Responsible Party: UConn Health
ClinicalTrials.gov Identifier: NCT01305902     History of Changes
Other Study ID Numbers: 11-040-2
P30DA023918 ( U.S. NIH Grant/Contract )
First Submitted: February 25, 2011
First Posted: March 1, 2011
Last Update Posted: June 18, 2012
Last Verified: June 2012

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders